Fundamentally Sound

Fundamentally Sound

HIMS: Redefining Personalized Healthcare & Scaling for the Future

A premium consumer experience with strong valuation growth: HIMS’ approach to personalized care and financial success.

Manu Invests's avatar
Manu Invests
Mar 24, 2025
∙ Paid

Business Overview

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. Hims & Hers Health is a founder-led, telehealth company that provides personalized healthcare and wellness solutions through a direct-to-consumer model. The company offers access to medical consultations, prescription treatments, and over-the-counter health products across various categories, including sexual health, mental health, weight loss, hair loss and more.

Financial Metrics (as of 3/21/25):

  • Price: $32.87

  • Market Cap: $7.44 billion

  • Shares: ~221 million

  • FCF/Share: .93

  • FCF Yield: 2.69%

  • SBC Adjusted FCF/Share: .50

  • SBC Adjusted FCF Yield: 1.44%

  • Forward FCF/Share = 1.29

  • FWD FCF Yield: 3.9

  • FWD EV/Sales: 3.01

  • Price/Sales: 5.03

  • FWD Price/Sales: 3.16

Potential Concerns Addressed Below:

  • Ending of the semaglutide (GLP-1) shortage by FDA.

  • Growth ex-GLP-1.

  • No moat?

  • Share dilution.

Company Highlights:

  • Incredible Growth:

    • Revenue: +95% QoQ, +69% YoY

    • Free Cash Flow: +4…

User's avatar

Continue reading this post for free, courtesy of Manu Invests.

Or purchase a paid subscription.
© 2026 Manu Invests · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture